Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.
about
Sulodexide and glycosaminoglycans in the progression of renal diseaseEpithelial-mesenchymal transition: An emerging target in tissue fibrosisImpact of heparanase on renal fibrosisFGF receptors: cancer biology and therapeuticsThe mutual impact of syndecan-1 and its glycosaminoglycan chains--a multivariable puzzle.FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell LinesSyndecan-1 in the mouse parietal peritoneum microcirculation in inflammation.PDGF-D expression is down-regulated by TGFβ in fibroblastsCadherin expression, vectorial active transport, and metallothionein isoform 3 mediated EMT/MET responses in cultured primary and immortalized human proximal tubule cellsTAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal InjurymiR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer CellsHeparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.Syndecan-1 (CD138) deficiency increases Staphylococcus aureus infection but has no effect on pathology in a mouse model of peritoneal dialysis.Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathwayScaffolding proteins DLG1 and CASK cooperate to maintain the nephron progenitor population during kidney developmentImplication of Bcl-2-associated athanogene 3 in fibroblast growth factor-2-mediated epithelial-mesenchymal transition in renal epithelial cells.Epithelial-mesenchymal status influences how cells deposit fibrillin microfibrils.The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line.Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes.Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition.Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.The advancements of heparanase in fibrosisHeparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.The bittersweet taste of tubulo-interstitial glycans.A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.Dialysis-related transcriptomic profiling: the pivotal role of heparanase.Interplay between transglutaminases and heparan sulphate in progressive renal scarring.Endothelial Cell Apoptosis Induces TGF-β Signaling-Dependent Host Endothelial-Mesenchymal Transition to Promote Transplant Arteriosclerosis.Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis.Heparanase and macrophage interplay in the onset of liver fibrosis.The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma
P2860
Q26991825-29DC520C-6ED3-43FD-ABC8-3A8D4DCB958FQ28083351-DD96B770-1091-4A55-BA61-7FD059D32903Q28083753-B74FCB7B-5994-4C75-A78B-AEF70FC79B73Q28291186-5D7E5870-9E63-4634-BA37-749EACB37881Q33354119-B709F92B-9BDE-4C62-9E18-AE65F45FA7A6Q33935206-B50CB05B-4EA1-48E6-88A7-BC714E77CFCBQ35237374-3DCBC350-40DD-426B-A0E6-41A4D6AD964CQ35299485-68FC13CE-0942-40B6-9968-3A02D3BF0BFBQ35585519-E737202C-7980-4AA0-9631-25F6C17F37DDQ35837781-36D32602-E9F7-40C5-9572-1CBCEFB284EDQ35864418-1A41E08D-8E5E-4481-8FB8-0EAF4CE783C1Q36088435-875C73C5-F8F2-4B60-863B-CF7AC543996BQ36531194-4DB6B0F2-9A43-45A3-8915-FB6719546779Q36797594-F170F9BE-AE87-4CEE-BD1C-C198084482F9Q36977379-8ECCF75F-1017-44BE-BD88-B057CDBE8B28Q37071172-019152E8-6324-4A85-A76D-B24075A47D4BQ37418467-D849C8A6-9313-473C-8E6B-D1A65AA23488Q38078480-00169962-CAEF-49B9-B796-D1052D366481Q38238094-904BE5A4-01BF-4892-BB19-D45721C180B3Q38376048-5D1AB6BA-0FD4-4AD5-9B5C-497739A285D0Q38709903-F947EABA-B06C-43E9-9A32-51239E4EDC57Q38985868-EB80574F-4F7D-4DD6-BF29-847981CF1AD9Q39033979-C5CB434C-9EAD-4491-9EC8-47E62CD4A8EAQ39060681-ABC0F926-17A8-41B7-AD82-792E3751E9D7Q39062384-868719A4-1FF9-49A1-8A01-FFE22D5C55FDQ39080564-33FC5AC7-DA24-47D5-BA64-4612BDDBF63BQ39120713-4FF7A41A-958B-4C96-9A4E-DBA1A277D94CQ39240506-B9AAF7D7-C8F8-4692-B8CF-E90CE6988EBBQ39254044-D626D5CF-8BD6-4188-A9BA-D8B70C002789Q39321185-771CC388-5A10-4C57-AF42-2A79972DC22EQ39330237-5983419D-9396-4AB2-8A4A-43ECD20987F4Q40537003-B10E8747-1F73-46C6-8617-0908F3AFB23CQ42742727-41F77C2C-CBF0-47B2-9CF1-3D35D2D84363Q43812376-B6764B05-BE9C-410E-82C4-BD9DA79B0C8FQ58554048-2224B0FC-9C65-4A7A-85FF-495B3A80B431
P2860
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@ast
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@en
type
label
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@ast
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@en
prefLabel
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@ast
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@en
P2093
P2860
P356
P1476
Heparanase and syndecan-1 inte ...... sition in renal tubular cells.
@en
P2093
Alessandra Gastaldello
Angela D'Angelo
Anna Maria Brunati
Antonio Lupo
Elena Tibaldi
Giovanni Gambaro
Maurizio Onisto
P2860
P304
P356
10.1074/JBC.M111.279836
P407
P577
2011-11-18T00:00:00Z